Wordt geladen...
Belimumab Concentrations in Maternal Serum and Breast Milk During Breastfeeding and the Safety Assessment of the Infant: A Case Study
Background: Belimumab is a recombinant human immunoglobulin G1 lambda monoclonal antibody that binds soluble B lymphocyte stimulator protein with high affinity and inhibits its biological activity. Belimumab is not recommended for breastfeeding women due to insufficient data about its excretion into...
Bewaard in:
| Gepubliceerd in: | Breastfeed Med |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Mary Ann Liebert, Inc., publishers
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7374635/ https://ncbi.nlm.nih.gov/pubmed/32326740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/bfm.2020.0068 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|